Our Mission:To discover,apply and disseminate knowledge through creative and innovative health research.

Publications

2013

1. Health-Care Providers' Perceptions Of Intravaginal Rings For Hiv Prevention In Nairobi, Kenya .

2. 2013, Pauli N. Amornkul, Etienne Karita Anatoli Kamali, Wasima N. Rida, Eduard J. Sanders, Shabir Lakhi,g Matt A. Price, William Kilembe, Emmanuel Cormier, Omu Anzala,h Mary H. Latka,Linda-Gail Bekker, Susan A. Allen, Jill Gilmour, and Patricia E. Fasta

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.

3. 2013, Daniela Bezemer, Nuno Rodrigues Faria, Amin Hassan, Raph L. Hamers, Gaudensia Mutua, Omu Anzala, Kishor Mandaliya, Patricia Cane, James A. Berkley, Tobias F. Rinke de Wit, Carole Wallis, Susan M. Graham, Matthew A. Price,Roel A. Coutinho, and Eduard J. Sanders

HIV Type 1 Transmission Networks Among Men Having Sex with Men and Heterosexuals in Kenya.

4. 2013 Heather A. Prentice, Matthew A. Price,  Travis R. Porter, Emmanuel Cormier, Michael J. Mugavero, Anatoli Kamali, Etienne Karita, Shabir Lakhi, Eduard J. Sanders,  Omu Anzala, Pauli N. Amornkul, Susan Allen,  Eric Hunter, Richard A. Kaslowa,  Jill Gilmour, Jianm

Dynamics of viremia in primary HIV-1 infection in Africans: Insights from analyses of host and viral correlates.

5. 2013, Marloes A. Naardinga, Natalia Fernandez, John C. Kappes, Peter Hayesa Tina Ahmed,  Mert Icyuz, Tara G. Edmonds , Philip Bergina, Omu Anzala, Tomas Hanke,  Lorna Clark, Josephine H. Cox, Emmanuel Cormier, Christina Ochsenbauer, Jill Gilmour

Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.

2012 

1. 2012, Jennifer E. Balkus, MPH, Walter Jaoko, MBChB, MMed, PhD, Kishorchandra Mandaliya, MBChB, Barbra A. Richardson, PhD, Linnet Masese, MBChB, MPH, Ruth Gitau, MBChB,James Kiarie, MBChB, MMed, MPH, Jeanne Marrazzo, MD, MPH, Carey Farquhar, MD, MPH, and R. Scott McClelland, MD, MPH

The Posttrial Effect of Oral Periodic Presumptive Treatment for Vaginal Infections on the Incidence of Bacterial Vaginosis and Lactobacillus Colonization.

2. 2012, Catherine A. Blish, MD, PhD, Scott McClelland, MD, MPH, Barbra A. Richardson, PhD, Walter Jaoko, MBChB, PhD, Kishorchandra Mandaliya, MBChB, MRCPath,Jared M. Baeten, MD, PhD and Julie Overbaugh, PhD.

Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.

3. 2012, Catherine A. Blish, Ozg C. Dogan, Walter Jaoko, R. Scott McClelland Kishorchand Mandaliya, Katherine S. Odem-Davisa, Barbra A. Richardsonb, and Julie Overbaugh

Cellular immune responses and susceptibility to HIV-1 superinfection: a case–control study.

4. 2012, Duncan Chege, Yijie Chai, Sanja Huibner, Taylor Kain, Charles Wachihi, Makubo Kimani, Samson Barasa, Lyle R. McKinnon, Festus K. Muriuki, Anthony Kariri, Walter Jaoko, Omu Anzala, Joshua Kimani, T. Blake Ball, Francis A. Plummer, Rupert Kaul

Blunted IL17/IL22 and Pro-Inflammatory Cytokine Responses in the Genital Tract and Blood of HIVExposed, Seronegative Female Sex Workers in Kenya.

5. 2012, Valerie Cortez, Katherine Odem-Davis, R. Scott McClelland, Walter Jaoko, Julie Overbaugh

HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response.

6. 2012, Susan M. Graham, MD, MPH, PhD, Zahra Jalalian-Lechak, BSc,Juma Shafi, MSc, Vrasha Chohan, BSc, Ruth W. Deya, MBChB, Walter Jaoko, MBChB, MSc, PhD, Kishor N. Mandaliya, MBChB, MRCPath,k Norbert M. Peshu, MBChB, MPH, DTCH Julie Overbaugh, PhD,and R. Scott McClelland, MD, MPH

Antiretroviral Treatment Interruptions Predict Female Genital Shedding of Genotypically Resistant HIV-1 RNA.

7. 2012, Barbara E. Kavanaugh, MPH, Katherine Odem-Davis, PhD, Walter Jaoko, MBChB, PhD,Benson Estambale, MBChB, PhD, James N. Kiarie, MBChB, MMed, MPH, Linnet N. Masese, MBChB, MPH,Ruth Deya, MBChB, Lisa E. Manhart, PhD, Susan M. Graham, MD, MPH, PhD,and Raymond Scott McClelland, MD, MPH

Prevalence and Correlates of Genital Warts in Kenyan Female Sex Workers.

8. 2012, Ann E. Kurth, CNM, PhD, FAAN Lauren McClelland, RN, MN, MPH, George Wanje, BA Annette E. Ghee, PhD Norbert Peshu, MBChB, MPH Esther Mutunga, KRN Walter Jaoko, MBChB, MTropMed, PhD Marta Storwick, RN, MSKing K. Holmes, MD, PhD Scott McClelland, MD, MPH.

An Integrated Approach for Antiretroviral Adherence and Secondary HIV Transmission Risk-Reduction Support by Nurses in Kenya.

9. 2012, Linnet N Masese, Susan M Graham, Ruth Gitau, Nobert Peshu, Walter Jaoko, Jeckoniah O Ndinya-Achola, Kishorchandra Mandaliya, Barbra A Richardson, Julie Overbaugh and R Scott McClelland

A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.

10. 2012, Lyle R. McKinnon, Nico J. Nagelkerke, Rupert Kaul, Souradet Y. Shaw, Rupert Capina,Ma Luo, Anthony Kariri, Winnie Apidi, Makobu Kimani, Charles Wachihi, Walter Jaoko, A. Omu Anzala, Joshua Kimani, T. Blake Ball, Francis A. Plummer

HIV-1 Clade D Is Associated with Increased Rates of CD4 Decline in a Kenyan Cohort.

11. 2012, R. Mdodo, K. Brown, E. Omonge, W. Jaoko, J. Baddley, P. Pappas, M.-Colette Kempf, I. Aban, S. Odera, A. Suleh And P. E. Jolly

The Prevalence, Clinical Features, Risk Factors And Outcome Associated With Cryptococcal Meningitis In Hiv Positive Patients In Kenya.

12. 2012, John J. Schellenberg, Tim J. Dumonceaux, Janet E. Hill, Joshua Kimani, Walter Jaoko, Charles Wachihi, Jane Njeri Mungai, Margo Lane, Keith R. Fowk, T. Blake Ball,Francis A. Plummer

Selection, Phenotyping and Identification of Acid and Hydrogen Peroxide Producing Bacteria from Vaginal Samples of Canadian and East African Women.

13. 2012, John J. Schellenberga, Catherine M. Carda, T. Blake Balla,c,d,Jane Njeri Mungaic, Erastus Irungu C, Joshua Kimanic, Walter Jaokoc,Charles Wachihi C, Keith R. Fowkea,B.D and Francis A. Plummera,C.D

Bacterial vaginosis, HIV serostatus and T-cell subset distribution in a cohort of East African commercial sex workers: retrospective analysis.

14. 2012, John H. Rogers, Elijah Odoyo-June, Walter Jaoko, Robert C. Bailey

Selection, Phenotyping and Identification of Acid and Hydrogen Peroxide Producing Bacteria from Vaginal Samples of Canadian and East African Women.

2011 

1. 2011, Jennifer E. Balkus, Barbra A. Richardson, Kishorchandra Mandaliya,James Kiarie,Walter Jaoko, Jeckoniah O. Ndinya-Achola,Jeanne Marrazzo,Carey Farquhar, and R. Scott McClelland

Establishing and Sustaining a HealthyVaginal Environment: Analysis of Data From a Randomized Trial of Periodic Presumptive Treatment for Vaginal Infections.

2. 2011, Susan M Graham,Linnet Masese, Ruth Gitau,Barbra A Richardson,Kishor Mandaliya,Norbert Peshu, Walter Jaoko,Jeckoniah Ndinya-Achola, Julie Overbaugh, R Scott McClelland

Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy.

3. 2011, R. Scott McClelland, MD, MPH, Barbra A. Richardson, PhD, George H. Wanje, BSc,Susan M. Graham, MD, MPH Esther Mutunga, Norbert Peshu, MBChB, MPH, DTCH,James N. Kiarie, MBChB, MPH, Ann E. Kurth, PhD, CNM, and Walter Jaoko, MBChB, PhD

Association between Participant Self-Report and Biological Outcomes Used to Measure Sexual Risk Behavior in HIV-1-Seropositive Female Sex Workers in Mombasa, Kenya.

4. 2011, Gloria S. Omosa-Manyonyi1*, Walter Jaoko1, Omu Anzala1, Hilda Ogutu1, Sabina Wakasiaka1, Roselyn Malogo1, Jacqueline Nyange1, Pamela Njuguna1, Jeckoniah Ndinya-Achola1, Kirana Bhatt1, Bashir Farah1, Micah Oyaro1, Claudia Schmidt2, Frances Priddy2, Patricia Fast2

Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI),Kenya.

5. 2011, Ruey-Chyi Su, Aida Sivro, Joshua Kimani,Walter Jaoko, Francis A Plummer and T Blake Ball

A transient IRF1 response in HIV-exposed, seronegative individuals differs from that in HIV-sucseptible controls and is governed by epigenetic mechanisms.

6. 2011, Laura M.Walker, Michael Huber Katie J. Doores, Emilia Falkowska, Robert Pejchal, Jean-Philippe Julien,Sheng-KaiWang, Alejandra Ramos, Po-Ying Chan-Hui, Matthew Moyle, Jennifer L. Mitcham, Phillip W. Hammond, Ole A. Olsen, Pham Phung, Steven Fling, Chi-HueyWong, Sanjay Phogat, Terri Wrin, Melissa D. Simek,Protocol G. Principal Investigators, Wayne C. Koff, Ian A. Wilson, Dennis R. Burton & Pascal Poignard

Broad neutralization coverage of HIV by multiple highly potent antibodies

2010 

1. 2010, Katherine A. Bosch , Stephanie Rainwater , Walter Jaoko , Julie Overbaugh A.

Temporal analysis of HIV envelope sequence evolution and antibody escape in a subtype A-infected individual with a broad neutralizing antibody response.

2. 2010, Duncan Chege1, Yijie Chai1, Sanja Huibner, Lyle McKinnon, Charles Wachihi, Makubo Kimani, Walter Jaoko, Joshua Kimani, T. Blake Bal, Francis A. Plummer, Rupert Kaul. Anuradha Rebbapragada

Evaluation of a Quantitative Real-Time PCR Assay to Measure HIV-Specific Mucosal CD8+ T Cell Responses in the Cervix.

3. 2010, Ruth W. Gitaua, Susan M. Grahama, Linnet N. Masesed, Julie Overbaughg, Vrasha Chohand, Norbert Peshuc, Barbra A. Richardsone,h, Walter Jaokoa, Jeckoniah O. Ndinya-Acholaa and R. Scott McClellanda

Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy.

4. 2010 Susan M. Graham, Linnet Masese, Ruth Gitau, Zahra Jalalian-Lechak, Barbra A. Richardson, Norbert Peshu, Kishor Mandaliya, James N. Kiarie, Walter Jaoko, Jeckoniah Ndinya-Achola, Julie Overbaugh, and R. Scott McClelland Antiretroviral Adherence and Development of Drug Resistance Are the Strongest Predictors of Genital HIV-1 Shedding among Women Initiating Treatment.

Antiretroviral Adherence and Development of Drug Resistance Are the Strongest Predictors of Genital HIV-1 Shedding among Women Initiating Treatment.

5. 2010, Walter Jaoko., Etienne Karita., Kayitesi Kayitenkore, Gloria Omosa-Manyonyi., Susan Allen, Soe Than4¤b, Elizabeth M. Adams, Barney S. Graham, Richard A. Koup, Robert T. Bailer, Carol Smith, Len Dally, Bashir Farah, Omu Anzala, Claude M. Muvunyi, Jean Bizimana, Tony Tarragona-Fiol, Philip J. Bergin, Peter Hayes, Martin Ho, Kelley Loughran, Wendy Komaroff, Gwynneth Stevens,Helen Thomson, Mark J. Boaz, Josephine H. Cox, Claudia Schmidt, Jill Gilmour, Gary J. Nabel,Patricia Fast, Job Bwayo.

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa

6. 2010, Rupert Kaula, Kelly S. MacDonalda, Nico J. Nagelkerkee, Joshua Kimani, Keith Fowke, T. Blake Ball, Ma Luo, Anthony Kariri, Walter Jaoko, Stephen Moses, Sarah Rowland-Jones and Francis A. Plummer,G.I

HIV viral set point and host immune control in individuals with HIV-specific CD8R T-cell responses prior to HIV acquisition

7. 2010, R. Scott McClelland,Susan M. Grahama, Barbra A. Richardson,Norbert Peshu, Linnet N. Masese, George H. Wanje, Kishorchandr N. Mandaliya, Ann E. Kurth, Walter Jaoko and Jeckonia O. Ndinya-Achola

Treatment with antiretroviral therapy is not associated with increased sexual risk behavior in Kenyan female sex workers.

8. 2010, Paul J. McLaren, T. Blake Ball,Charles Wachihi, Walter Jaoko, David J. Kelvin, Ali Danesh, Joshua Kimani,Francis A. Plummer,and Keith R. Fowke

HIV-Exposed Seronegative Commercial Sex Workers Show a Quiescent Phenotype in the CD4+ T Cell Compartment and Reduced Expression of HIV-Dependent Host Factors.

9. 2010, Rennatus Mdodo, Stephen A. Moser, Walter Jaoko, John Baddley,Peter Pappas, Mirjam-Colette Kempf, Inmaculada Aban, Susan Odera and Pauline Jolly

Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya. 

2009 

1. 2009, J M Baeten, W M Hassan, V Chohan, B A Richardson, K Mandaliya,

J O Ndinya-Achola, W Jaoko, R S McClelland

Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women.

2. 2009, V Chohan, J M Baeten,S Benki, S M Graham ,L Lavreys,K Mandaliya, J O Ndinya-Achola, W Jaoko, J Overbaugh, R S McClelland

A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya.

3. 2009, Tim J. Dumoncea John Schellenberg, Vanessa Goleski, Janet E. Hill, Walter Jaoko,Joshua Kimani, Deborah Money,T. Blake Ball,Francis A. Plummer, and Alberto Severini

Multiplex Detection of Bacteria Associated with Normal Microbiota and with Bacterial Vaginosis in Vaginal Swabs by Use of Oligonucleotide-Coupled Fluorescent Microspheres.

4. 2009, Susan M. Graham, MD, MPH, Linnet Masese, MBChB, MPH, Ruth Gitau, MBChB,DicksonMwakangalu, MBChB, Walter Jaoko,MBChB, PhD, Jeckoniah Ndinya-Achola,MBChB,MSc, Kishor Mandaliya, MBChB, MRCPath,k Norbert Peshu, MBChB, MPH, DTCH, Jared M. Baeten, MD, PhD, and R. Scott McClelland, MD, MPH

Increased Risk of Genital Ulcer Disease in Women During the First Month After Initiating Antiretroviral Therapy

5. 2009, Rachel E. Horton,1 T. Blake Ball, Charles Wachichi,Walter Jaoko,W. John Rutherford, Lyle Mckinnon, Rupert Kaul, Anu Rebbapragada, Joshua Kimani,and Frank A. Plummer

Cervical HIV-Specific IgA in a Population of Commercial Sex Workers Correlates with Repeated Exposure But Not Resistance to HIV.

6. 2009, Shehzad M. Iqbala, Terry B. Balla,Pauline Levinson, Lillian Maranana, Walter Jaoko, Charles Wachihi, Brian J. Pak, Vladimir N. Podust, Kristina Broliden, Taha Hirbob, Rupert Kaule and Francis A. Plummera,

Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition.

7. 2009, W. G. Jaoko, H. Ogutu, S. Wakasiaka, R. Malogo, R. Ndambuki, J. Nyange, G. Omosa-Manyonyi, P. Fast, C. Schmidt, C. Verlinde, C. Smith, K.M. Bhatt, J. Ndinya-Achola And O. Anzala

Pregnancy Rates Among Female Participants In Phase I And Phase Iia Aids Vaccine Clinical Trials In Kenya.

8. 2009, Etienne Karita, Nzeera Ketter, Matt A. Price, Kayitesi Kayitenkore, Pontiano Kaleebu, Annet Nanvubya, Omu Anzala, Walter Jaoko, Gaudensia Mutua, Eugene Ruzagira, Joseph Mulenga, Eduard J. Sanders, Mary Mwangome, Susan Allen, Agnes Bwanika, Ubaldo Bahemuka, Ken Awuondo, Gloria Omosa3, Bashir Farah, Pauli Amornkul, Josephine Birungi, Sarah Yates, Lisa Stoll-Johnson, Jill Gilmour, Gwynn Stevens, Erin Shutes, Olivier Manigart, Peter Hughes, Len Dally, Janet Scott, Wendy Stevens, Pat Fast, Anatoli Kamali

CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa.

9. 2009, Richard T. Lestera,b,1, Walter Jaokob, Francis A. Plummera,c, and Rupert Kaula,d

Sex, microbial translocation, and the African HIV epidemic.

10. 2009, Etienne Karita, Nzeera Ketter, Matt A. Price, Kayitesi Kayitenkore, Pontiano Kaleebu, Annet Nanvubya, Omu Anzala, Walter Jaoko, Gaudensia Mutua, Eugene Ruzagira, Joseph Mulenga, Eduard J. Sanders , Mary Mwangome, Susan Allen, Agnes Bwanika, Ubaldo Bahemuka, Ken Awuondo, Gloria Omosa, Bashir Farah, Pauli Amornkul, Josephine Birungi, Sarah Yates, Lisa Stoll-Johnson, Jill Gilmour, Gwynn Stevens, Erin Shutes, Olivier Manigart, Peter Hughes, Len Dally, Janet Scott, Wendy Stevens, Pat Fast, Anatoli Kamali

CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa. 11.HIV-1 RNA Dysregulates the Natural TLR Response to Subclinical Endotoxemia in Kenyan Female Sex-Workers.

12. 2009, Mecky I Matee1, Christine Manyando2, Peter M Ndumbe3, Tumani Corrah4, Walter G Jaoko†5, Andrew Y Kitua†6, Herman PA Ambene†7, Mathieu Ndounga†8, Lynn Zijenah†9, David Ofori- Adjei†10, Simon Agwale†11, Steven Shongwe†12, Thomas Nyirenda†13 and Michael Makanga†13

European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership.

13. 2009, Lyle R. McKinnon,1,2 Rupert Capina,3 Harold Peters,3 Mark Mendoza,3 Joshua Kimani,1,2 Charles Wachihi,2 Anthony Kariri,2 Makobu Kimani,2 Meika Richmond,1 Sandy Koesters Kiazyk,4 Keith R. Fowke,1,2 Walter Jaoko,2 Ma Luo,3 T. Blake Ball,1,2,4,5 and Francis A. Plummer1,2,3,4

Clade-Specific Evolution Mediated by HLA-B*57/5801 in Human Immunodeficiency Virus Type 1 Clade A1.

14. 2009, R. Scott McClelland,1,2,5 Barbra A. Richardson,3 Wisal M. Hassan,2 Susan M. Graham,1,5 James Kiarie,1,6 Jared M. Baeten,1,4 Kishorchandra Mandaliya,7 Walter Jaoko,5 Jeckoniah O. Ndinya-Achola,5 and King K. Holmes1,4

Prospective Study of Vaginal Bacterial Flora and Other Risk Factors for Vulvovaginal Candidiasis.

15. 2009, Julius O. Oyugi,1,a Françoise C. M. Vouriot,1,a Judie Alimonti,3 Stephen Wayne,1 Ma Luo,1 Allison M. Land,1 Zhujun AO,1 Xiaojian Yao,1 Rafick P. Sekaly,4 Lawrence J. Elliott,2 J. Neil Simonsen,3 T. Blake Ball,1,5 Walter Jaoko,5 Joshua Kimani,5 Francis A. Plummer,1,2,3 and Keith R. Fowke1,2,5

A Common CD4 Gene Variant Is Associated with an Increased Risk of HIV-1 Infection in Kenyan Female Commercial Sex Workers.

16. 2009, Melissa D. Simek,1*‡ Wasima Rida,10‡ Frances H. Priddy,1 Pham Pung,2 Emily Carrow,9 Dagna S. Laufer,1 Jennifer K. Lehrman,1 Mark Boaz,1§ Tony Tarragona-Fiol,17 George Miiro,5 Josephine Birungi,6 Anton Pozniak,8 Dale A. McPhee,7 Olivier Manigart,4 Etienne Karita,4 Andre´ Inwoley,11 Walter Jaoko,12 Jack DeHovitz,13 Linda-Gail Bekker,14 Punnee Pitisuttithum,15 Robert Paris,16 Laura M. Walker,3 Pascal Poignard,3 Terri Wrin,2 Patricia E. Fast,1 Dennis R. Burton,3 and Wayne C. Koff1

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm_†

17. 2009, Kim Steegen1,2,3,6, Stanley Luchters1,2, Kenny Dauwe3, Jacqueline Reynaerts3, Kishor Mandaliya4, Walter Jaoko5, Jean Plum3, Marleen Temmerman1 and Chris Verhofstede

Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya.

18. 2009, Laura M. Walker,1* Sanjay K. Phogat,2*‡ Po-Ying Chan-Hui,3 Denise Wagner,2 Pham Phung,4 Julie L. Goss,4 Terri Wrin,4 Melissa D. Simek,5 Steven Fling,1 Jennifer L. Mitcham,3 Jennifer K. Lehrman,5 Frances H. Priddy,5 Ole A. Olsen,3 Steven M. Frey,3 Phillip W. Hammond,3Protocol G Principal Investigators,† Stephen Kaminsky,2 Timothy Zamb,2 Matthew Moyle,3 Wayne C. Koff,5 Pascal Poignard,1 Dennis R. Burton1,6‡

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target.

2008 

2008, Walter Jaokoa, Frederick N. Nakwagalab, Omu Anzalaa, Gloria Omosa Manyonyia, Josephine Birungib, Annet Nanvubyab, Farah Bashira, Kirana Bhatta, Hilda Ogutua, Sabina Wakasiakaa,Lucy Matua,1, Wambui Waruingi a,2, Jane Odadaa, Micah Oyaroa, Jackton Indangasia, Jeckonia Ndinya-Acholaa, Carol Kondeb, Emmanuel Mugishab,3, Patricia Fast C, Claudia Schmidtc, Jill Gilmourd,

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.

Tony Tarragonad, Carol Smithe, Burc Barine, Len Dally e, Bruce Johnsonc, Andrew Muluubyab, Leslie Nielsenc, Peter Hayesd, Mark Boazd, Peter Hughesf, Tom A.S Hankeg, Andrew McMichaelg, Job Bwayoa,4, Pontiano Kaleebub,f

2. 2008, Be´ne´dicte Roqueberta,b, Laurent Blumc, Gilles Collina, Florence Damonda, Gilles Peytavind, Juliette Leleua, Sophie Matheronb,e, Genevie`ve Cheˆnef, Franc¸Oise

Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen.

3. 2008, Richard T. Lestera,b, Xiao-Dan Yaoc, T. Blake Balla, Lyle R. McKinnona,Rupert Kauld, Charles Wachihib, Walter Jaokob, Francis A. Plummera and Kenneth L. Rosenthalc.

Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.

4. 2008, R. Scott McClelland,1,2,6 Barbra A. Richardson,3 Wisal M. Hassan,2 Vrasha Chohan,6 Ludo Lavreys,2,6 Kishorchandra Mandaliya,8 James Kiarie,7 Walter Jaoko,6 Jeckoniah O. Ndinya-Achola,6 Jared M. Baeten,1 Ann E. Kurth,5 and King K. Holmes1,4

Improvement of Vaginal Health for Kenyan Women at Risk for Acquisition of Human

Immunodeficiency Virus Type 1: Results of a Randomized Trial.

5. 2008, R. Scott Mcclelland, Md, Mph, Barbra A. Richardson, Phd,§ Susan M. Graham, Md, Mph, Linnet N. Masese, Mbchb,†‡ Ruth Gitau, Mbchb,‡ Ludo Lavreys, Md, Phd, Kishorchandra Mandaliya, Mbchb,_ Walter Jaoko, Mbchb, Mmed, Phd,‡ Jared M. Baeten, Md, Phd,* And Jeckoniah O. Ndinya-Achola, Mbchb, Mmed, Msc

A Prospective Study of Risk Factors for Bacterial Vaginosis in HIV-1-Seronegative African Women.

6. 2008, Anuradha Rebbapragada, PhD, Kathryn Howe, PhD, Charles Wachihi, MCChB,Christopher Pettengell, BSc, Sherzana Sunderji, BSc, Sanja Huibner, BSc, T. Blake Ball, PhD, Francis A. Plummer, MD, Walter Jaoko, PhD, MBChB, and Rupert Kaul, MD, PhD

Bacterial Vaginosis in HIV-Infected Women Induces Reversible Alterations in the Cervical Immune Environment.

7. 2008, Paul E. Simonsena, DanW. Meyrowitschb,Walter G. Jaokoc, Mwele N. Malecelad, Edwin Michaele.

Immunoepidemiology of Wuchereria bancrofti infection in two East African

communities: Antibodies to the microfilarial sheath and their role in regulating host microfilaraemia.

8. 2008, Wendy Stevens1, Anatoli Kamali2, Etienne Karita3, Omu Anzala4, Eduard J. Sanders5, Walter Jaoko4,Pontiano Kaleebu2, Joseph Mulenga6, Len Dally7, Pat Fast8, Jill Gilmour8, Bashir Farah4, Josephine Birungi9, Peter Hughes2, Olivier Manigart6, Gwynn Stevens8, Sarah Yates8, Helen Thomson8, Andrea von Lieven8, Marietta Krebs8, Matt A. Price8, Lisa Stoll-Johnson10, Nzeera Ketter11

Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials.

 2006 

 1. 2006, Susan M. Grahama,g, Sarah E. Holteb,d, Norbert M. Peshuf, Barbra A. Richardsonb, Dana D. Panteleeff e, Walter G. Jaokog, Jeckoniah O. Ndinya- Acholag, Kishorchandra N. Mandaliyah, Julie M. Overbaughe and R. Scott McClellanda,C.G

Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

2. 2006, Walter G. Jaoko, Paul E. Simonsen, Dan W. Meyrowitsch, Benson B. A. Estambale, Mwele N. Malecela-Lazaro, And Edwin Michael.

Filarial-Specific Antibody Response In East African Bancroftian Filariasis: Effects Of Host Infection, Clinical Disease, Andfilarial Endemicity.

3. 2006, R. Scott McClellanda,b,f, Wisal M. Hassanf, Ludo Lavreysb,f, Barbra A. Richardsonc,e, Kishorchandra Mandaliyag, Jeckoniah Ndinya-Acholaf, Walter Jaokof, Ann E. Kurthb,D and Jared M. Baetena

HIV-1 acquisition and disease progression are associated with decreased high-risk sexual behavior among Kenyan female sex workers.

4. 2006, Barry S. Peters a, Walter Jaoko b, Eftyhia Vardas c, George Panayotakopoulos a, Patricia Fast d, Claudia Schmidt d, Jill Gilmour d, Mampedi Bogoshi c, Gloria Omosa-Manyonyi b, Len Dally e, Linda Klavinskis a, Bashir Farah b, Tony Tarragona f, Pierre-Alexandre Bart g, Andrew Robinson h, Colleen Pieterse h, Wendy Stevens i, Richard Thomasj, Burc Barin e, Andrew J. McMichaelk, James A. McIntyre c, Giuseppe Pantaleo g, Tom´aˇs Hanke k, Job Bwayo B

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity. 2007 Publications

5. 2006, Jared M. Baeten,1,a Bhavna Chohan,2,a Ludo Lavreys,3,7 Vrasha Chohan,7 R. Scott McClelland,1,3,7 Laura Certain,4 Kishorchandra Mandaliya,8 Walter Jaoko,7 and Julie Overbaugh5,6

HIV-1 Subtype D Infection Is Associated with Faster Disease Progression than Subtype A in Spite of Similar Plasma HIV-1 Loads.

6. 2006, Jared M. Baetena, Sarah Benkic, Vrasha Chohane, LudoLavreysb,e, R. Scott McClellanda,b,e, Kishorchandra Mandaliyaf, Jeckoniah O. Ndinya-Acholae, Walter Jaokoe and Julie Overbaughc,D

Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women

7. 2006, Susan M. Grahama,g, Sarah E. Holteb,d, Norbert M. Peshuf, Barbra A. Richardsonb, Dana D. Panteleeff e, Walter G. Jaokog, Jeckoniah O. Ndinya- Acholag, Kishorchandra N. Mandaliyah, Julie M. Overbaughe and R. Scott McClellanda,C.G

Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

8. 2006, Wisal M. Hassan, Mbchb, Mph, Ludo Lavreys, Md, Msc, Phd,Vrasha Chohan, Bsc,§ Barbra A. Richardson, Phd Kishorchandra Mandaliya, Mbchb, Frcp, Jeckoniah O. Ndinya-Achola, Mbchb, Msc,James Kiarie, Mbchb, Mmed, Mph,_Walter Jaoko, Mbchb, Mtmed, Phd, King K. Holmes, Md, Phd, And R. Scott Mcclelland, Md, Mph

Associations Between Intravaginal Practices and Bacterial Vaginosis in Kenyan Female Sex Workers Without Symptoms of Vaginal Infections.

9. 2006, Walter G. Jaoko,1 Edwin Michael,2 Dan W. Meyrowitsch,3 Benson B. A. Estambale,1 Mwele N. Malecela,4 and Paul E. Simonsen5

Immunoepidemiology of Wuchereria bancrofti Infection: Parasite Transmission Intensity, Filaria-Specific Antibodies, and Host Immunity in Two East African Communities.

10. 2006, R. Scott McClelland,1,2,3 Laura Sangare ,2 Wisal M. Hassan,3 Ludo Lavreys,2,3 Kishorchandra Mandaliya,5 James Kiarie,4Jeckoniah Ndinya-Achola,3 Walter Jaoko,3 and Jared M. Baeten1

Infection with Trichomonas vaginalis Increases the Risk of HIV-1 Acquisition

11. 2006, Anuradha Rebbapragadaa, Charles Wachihic, Christopher Pettengella, Sherzana Sunderjia, Sanja Huibnera, Walter Jaokoc, Blake Balld, Keith Fowked, Tony Mazzullie, Francis A. Plummerd and Rupert Kaula,B.C.F

Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.

12. 2006, Kim Steegen,1,2,3 Stanley Luchters,1,2 Els Demecheleer,3 Kenny Dauwe,3 Kishor Mandaliya,4 Walter Jaoko,5 Jean Plum,3 Marleen Temmerman,1 and Chris Verhofstede3

Feasibility of Detecting Human Immunodeficiency Virus Type 1 Drug Resistance in DNA Extracted from Whole Blood or Dried Blood Spots.

13. 2006, Kim Steegen a,b,c,, Stanley Luchters a,b, Nancy De Cabooter c, Jacqueline Reynaerts c, Kishor Mandaliya d, Jean Plumc, Walter Jaoko e, Chris Verhofstede c, Marleen Temmermans

Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings.

 2005 

1. 2005, Reference Ouma, Naftal Masese, Walter G. Jaoko, And Edwin Michael.

The Effect Of Repeated Half-Yearly Diethylcarbamazine Mass Treatment On Wuchereria Bancrofti Infection And Transmission In Two East African Communities With Different Levels Of Endemicity.

2. 2005, Paul E. Simonsena, Stephen M. Magesab, Dan W. Meyrowitschc, Mwele N. Malecela-Lazarod, Rwehumbiza T. Rwegoshora B, Walter G. Jaoko E, Edwin Michael F

The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia

 2004 

2004, Tara Beattiea, Rupert Kaulb, Tim Rostrona, Tao Donga,Philippa Easterbrookc, Walter Jaokod, Joshua Kimanid, Francis Plummere, Andrew McMichaela and Sarah Rowland-Jonesa

Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes.

2. 2004, Paul E. Simonsen, Dan W. Meyrowitsch, Dunstan A. Mukoko, Erling M. Pedersen,Mwele N. Malecela-Lazaro, Rwehumbiza T. Rwegoshora, John H. Ouma, Naftal Masese, Walter G. Jaoko, And Edwin Michael

The Effect Of Repeated Half-Yearly Diethylcarbamazine Mass Treatment On Wuchereria Bancrofti Infection And Transmission In Two East African Communities With Different Levels Of Endemicity.

 2002 

 1.2002, Paul E. Simonsen, Dan W. Meyrowitsch, Walter G. Jaoko, Mwele N. Malecela, Dunstan Mukoko, Erling M. Pedersen, John H. Ouma, Rwehumbisa T. Rwegoshora, Naftal Masese, Pascal Magnussen, Benson B. A. Estambale, And Edwin Michael

Bancroftian Filariasis Infection, Disease, And Specific Antibody Response Patterns In A High And A Low Endemicity Community In East Africa.

2001

1.2000, K Fonck, N Kidula,W Jaoko, B Estambale, P Claeys, J Ndinya-Achola, P Kirui, J Bwayo,M Temmerman.

Validity of the vaginal discharge algorithm among pregnant and non-pregnant women in Nairobi,Kenya

end faq